Personalized Medicine and Epigenomics Market Report

Global and Region Personalized Medicine and Epigenomics Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 31, 2022
  • PAGES：169
  • REPORT CODE：GMM939997
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Epigenomics is the study of the complete set of epigenetic modifications on the genetic material of a cell, known as the epigenome. The field is analogous to genomics and proteomics, which are the study of the genome and proteome of a cell.

    The report details the trend, potential and market size of Personalized Medicine and Epigenomics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Personalized Medicine and Epigenomicsmarket, defines the market attractiveness level of Personalized Medicine and Epigenomics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Personalized Medicine and Epigenomics industry, describes the types of Personalized Medicine and Epigenomics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Personalized Medicine and Epigenomics market and the development prospects and opportunities of Personalized Medicine and Epigenomics industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Personalized Medicine and Epigenomics market in Chapter 13.

    By Player:

    • Company 1

    • Company 2

    • Company 3

    • Company 4

    • Company 5

    • Company 6

    • Company 7

    • Company 8

    • Company 9

    • Company 10

    By Type:

    • Reagents

    • Kits

    • Instruments

    • Enzymes

    • Services

    By End-User:

    • Oncology

    • Non-Oncology

    • Cancer Drug Technology

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Personalized Medicine and Epigenomics Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Personalized Medicine and Epigenomics Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Personalized Medicine and Epigenomics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Personalized Medicine and Epigenomics Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Personalized Medicine and Epigenomics Market Analysis and Outlook to 2022

    • 7.1 Global Personalized Medicine and Epigenomics Consumption (2017-2022)

    • 7.2 United States Personalized Medicine and Epigenomics Consumption (2017-2022)

    • 7.3 Europe Personalized Medicine and Epigenomics Consumption (2017-2022)

    • 7.4 China Personalized Medicine and Epigenomics Consumption (2017-2022)

    • 7.5 Japan Personalized Medicine and Epigenomics Consumption (2017-2022)

    • 7.6 India Personalized Medicine and Epigenomics Consumption (2017-2022)

    • 7.7 South Korea Personalized Medicine and Epigenomics Consumption (2017-2022)

    8 Region and Country-wise Personalized Medicine and Epigenomics Market Analysis and Outlook to 2028

    • 8.1 Global Personalized Medicine and Epigenomics Consumption Forecast (2022-2028)

    • 8.2 United States Personalized Medicine and Epigenomics Consumption Forecast (2022-2028)

    • 8.3 Europe Personalized Medicine and Epigenomics Consumption Forecast (2022-2028)

    • 8.4 China Personalized Medicine and Epigenomics Consumption Forecast (2022-2028)

    • 8.5 Japan Personalized Medicine and Epigenomics Consumption Forecast (2022-2028)

    • 8.6 India Personalized Medicine and Epigenomics Consumption Forecast (2022-2028)

    • 8.7 South Korea Personalized Medicine and Epigenomics Consumption Forecast (2022-2028)

    9 Global Personalized Medicine and Epigenomics Market Outlook by Types and Applications to 2022

    • 9.1 Global Personalized Medicine and Epigenomics Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Reagents Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Kits Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Instruments Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Enzymes Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Services Consumption and Growth Rate (2017-2022)

    • 9.2 Global Personalized Medicine and Epigenomics Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Non-Oncology Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cancer Drug Technology Consumption and Growth Rate (2017-2022)

    10 Global Personalized Medicine and Epigenomics Market Outlook by Types and Applications to 2028

    • 10.1 Global Personalized Medicine and Epigenomics Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Reagents Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Kits Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Instruments Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Enzymes Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Services Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Personalized Medicine and Epigenomics Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Non-Oncology Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cancer Drug Technology Consumption Forecast and Growth Rate (2022-2028)

    11 Global Personalized Medicine and Epigenomics Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Personalized Medicine and Epigenomics Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Personalized Medicine and Epigenomics Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Personalized Medicine and Epigenomics Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Personalized Medicine and Epigenomics Market Competitive Analysis

    • 14.1 Company 1

      • 14.1.1 Company 1 Company Details

      • 14.1.2 Company 1 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Company 1 Personalized Medicine and Epigenomics Product and Service

    • 14.2 Company 2

      • 14.2.1 Company 2 Company Details

      • 14.2.2 Company 2 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Company 2 Personalized Medicine and Epigenomics Product and Service

    • 14.3 Company 3

      • 14.3.1 Company 3 Company Details

      • 14.3.2 Company 3 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Company 3 Personalized Medicine and Epigenomics Product and Service

    • 14.4 Company 4

      • 14.4.1 Company 4 Company Details

      • 14.4.2 Company 4 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Company 4 Personalized Medicine and Epigenomics Product and Service

    • 14.5 Company 5

      • 14.5.1 Company 5 Company Details

      • 14.5.2 Company 5 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Company 5 Personalized Medicine and Epigenomics Product and Service

    • 14.6 Company 6

      • 14.6.1 Company 6 Company Details

      • 14.6.2 Company 6 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Company 6 Personalized Medicine and Epigenomics Product and Service

    • 14.7 Company 7

      • 14.7.1 Company 7 Company Details

      • 14.7.2 Company 7 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Company 7 Personalized Medicine and Epigenomics Product and Service

    • 14.8 Company 8

      • 14.8.1 Company 8 Company Details

      • 14.8.2 Company 8 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Company 8 Personalized Medicine and Epigenomics Product and Service

    • 14.9 Company 9

      • 14.9.1 Company 9 Company Details

      • 14.9.2 Company 9 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Company 9 Personalized Medicine and Epigenomics Product and Service

    • 14.10 Company 10

      • 14.10.1 Company 10 Company Details

      • 14.10.2 Company 10 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Company 10 Personalized Medicine and Epigenomics Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Personalized Medicine and Epigenomics

    • Figure Personalized Medicine and Epigenomics Picture

    • Table Global Personalized Medicine and Epigenomics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Personalized Medicine and Epigenomics Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Personalized Medicine and Epigenomics Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Personalized Medicine and Epigenomics Consumption by Country (2017-2022)

    • Figure United States Personalized Medicine and Epigenomics Consumption and Growth Rate (2017-2022)

    • Table Europe Personalized Medicine and Epigenomics Consumption and Growth Rate (2017-2022)

    • Figure China Personalized Medicine and Epigenomics Consumption and Growth Rate (2017-2022)

    • Figure Japan Personalized Medicine and Epigenomics Consumption and Growth Rate (2017-2022)

    • Figure India Personalized Medicine and Epigenomics Consumption and Growth Rate (2017-2022)

    • Figure South Korea Personalized Medicine and Epigenomics Consumption and Growth Rate (2017-2022)

    • Figure Global Personalized Medicine and Epigenomics Consumption Forecast by Country (2022-2028)

    • Figure United States Personalized Medicine and Epigenomics Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Personalized Medicine and Epigenomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Personalized Medicine and Epigenomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Personalized Medicine and Epigenomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Personalized Medicine and Epigenomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Personalized Medicine and Epigenomics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Reagents Consumption and Growth Rate (2017-2022)

    • Figure Global Kits Consumption and Growth Rate (2017-2022)

    • Figure Global Instruments Consumption and Growth Rate (2017-2022)

    • Figure Global Enzymes Consumption and Growth Rate (2017-2022)

    • Figure Global Services Consumption and Growth Rate (2017-2022)

    • Figure Global Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Non-Oncology Consumption and Growth Rate (2017-2022)

    • Figure Global Cancer Drug Technology Consumption and Growth Rate (2017-2022)

    • Figure Global Reagents Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Kits Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Instruments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Enzymes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Services Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Non-Oncology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cancer Drug Technology Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Personalized Medicine and Epigenomics Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Personalized Medicine and Epigenomics Export by Region (Top 5 Countries) (2017-2028)

    • Table Company 1 (Foundation Year, Company Profile and etc.)

    • Table Company 1 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 1 Personalized Medicine and Epigenomics Product and Service

    • Table Company 2 (Foundation Year, Company Profile and etc.)

    • Table Company 2 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 2 Personalized Medicine and Epigenomics Product and Service

    • Table Company 3 (Foundation Year, Company Profile and etc.)

    • Table Company 3 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 3 Personalized Medicine and Epigenomics Product and Service

    • Table Company 4 (Foundation Year, Company Profile and etc.)

    • Table Company 4 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 4 Personalized Medicine and Epigenomics Product and Service

    • Table Company 5 (Foundation Year, Company Profile and etc.)

    • Table Company 5 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 5 Personalized Medicine and Epigenomics Product and Service

    • Table Company 6 (Foundation Year, Company Profile and etc.)

    • Table Company 6 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 6 Personalized Medicine and Epigenomics Product and Service

    • Table Company 7 (Foundation Year, Company Profile and etc.)

    • Table Company 7 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 7 Personalized Medicine and Epigenomics Product and Service

    • Table Company 8 (Foundation Year, Company Profile and etc.)

    • Table Company 8 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 8 Personalized Medicine and Epigenomics Product and Service

    • Table Company 9 (Foundation Year, Company Profile and etc.)

    • Table Company 9 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 9 Personalized Medicine and Epigenomics Product and Service

    • Table Company 10 (Foundation Year, Company Profile and etc.)

    • Table Company 10 Personalized Medicine and Epigenomics Sales, Price, Value and Gross Profit (2017-2022)

    • Table Company 10 Personalized Medicine and Epigenomics Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US